Home | Coriolis Pharma

Coriolis Pharma Formulating innovation

We enable innovative therapies by revolutionizing formulation development.

Formulation Development

“It is a medicine, not a molecule, that we are giving to the patient” Marc B. Brown, 2005.

Coriolis is the expert in developing liquid and lyophilized formulations for a large variety of different (bio)pharmaceutical molecules, including proteins, peptides, nucleic acids, ATMPs, GMOs, vaccines and virus(-like) particles.

Find out how we can support your drug development...

Analytical Services

A highly diverse analytical portfolio entirely performed in-house: This is Coriolis.

With the latest in technology and highly experienced scientists, we are a trendsetter in the field. We provide our analytical services for samples up to biosafety level S2 under R&D and cGMP conditions, including method development, qualification and validation.

Get to know our services...

About us

Independent, reliable and always on the cutting edge of science. Coriolis is a leading service provider for formulation research and development of (bio)pharmaceutical drugs and vaccines.

Get to know us...

2022/01/17

Prof. Dr. Hristo Svilenov joins our Scientific Advisory Board

We welcome Prof. Dr. Hristo Svilenov as a new Scientific Advisory Board Member and expert in formulation development of biotherapeutics

2021/12/20

Coriolis spreads the Christmas spirit

Following our yearly tradition, we are donated 23,000 € to several charity organizations, which were selected by our employees.

2021/11/17

Coriolis AUC Expert gives Talk at the Gene and Cell Therapy Conference

Dr. Klaus Richter will speak about "Assessing Critical Quality Attributes of viral vectors for gene therapy" at conference in Munich.

2021/11/05

Meet us at the Festival of Biologics in Basel

Fund us at booth 51 and arrange your face-to-face meeting with our experts on site.

2021/10/05

A Sunny Sailing Trip at the Starnberg Lake

Coriolis employees enjoyed a wonderful sailing day with the Coriolis-sponsored GFK Team on the H-boat "Kiaora"

2021/10/04

Meet us at the PEGS Europe Summit in Barcelona

Find us at booth 210 and listen to our Scientific Advisor Prof. Kersten's talk about "mRNA-Based COVID-19 Vaccines"

2021/09/13

Coriolis supports live discussion forum BioM Science & Health

The BioM Forum is an interdisciplinary discussion platform making scientific viewpoints available to the public. Coriolis is gold sponsors of the next session about mRNA and gene therapy.

2021/09/08

Prof. Dr. Susumu Uchiyama joins Scientific Advisory Board of Coriolis

We welcome Prof. Dr. Susumu Uchiyama as a new Scientific Advisory Board Member and expert for viral vectors for gene therapy.

2021/09/06

Coriolis-sponsored sailing team happy with 2021 world cup race

The GFK racing team achieved a fantastic 10th place at the H-boat world cup race in Denmark.

2021/08/31

In Memoriam Prof. Dr. Wim Jiskoot (1961 – 2021), Scientific Advisor of Coriolis

We will remember Wim as the openminded, brilliant, and honest person, who stayed positive even after a devastating diagnosis. Our thoughts are with his loved ones, in particular Karin, Julia and Carles.

View all

Latest publications

Particles in Biopharmaceutical Formulations, Part 2

Alexandra Roescha, Sarah Zölls, Daniela Stadler, Constanze Helbig, Klaus Wuchner, Gideon Kersten, Andrea Hawe, Wim Jiskoot and Tim Menzen

Ongoing challenges to develop high concentration monoclonal antibody-based formulations for subcutaneous administration: Quo Vadis?

Wim Jiskoot †, Andrea Hawe, Tim Menzen, David B. Volkin, Daan J.A. Crommelin

Development and Application of a Mechanistic Cooling and Freezing Model of the Spin Freezing Step within the Framework of Continuous Freeze-Drying

Gust Nuytten, Susan Ríos Revatta, Pieter-Jan Van Bockstal, Ashish Kumar, Joris Lammens, Laurens Leys, Brecht Vanbillemont, Jos Corver, Chris Vervaet and Thomas De Beer

An Interlaboratory Comparison on the Characterization of a Sub-micrometer Polydisperse Particle Dispersion

Kurt D Benkstein, Gurusamy Balakrishnan, Ashwinkumar Bhirde, Pascal Chalus, Tapan K Das, Ngoc Do, David L Duewer, Nazar Filonov, Fook Chiong Cheong, Patrick Garidel, Nicole S Gill, Adam D Grabarek, David G Grier, Judith Hadley, Andrew D Hollingsworth, Wesley W Howard, Maciej Jarzębski, Wim Jiskoot, Sambit R Kar, Vikram Kestens, Harshit Khasa, Yoen Joo Kim, Atanas Koulov, Anja Matter, Laura A Philips, Christine Probst, Yannic Ramaye, Theodore W Randolph, Dean C Ripple, Stefan Romeijn, Miguel Saggu, Franziska Schleinzer , Jared R Snell, Jan Kuba Tatarkiewicz, Heather Anne Wright, Dennis T Yang

Continuous milli-scale reaction calorimeter for direct scale-up of flow chemistry

Marlies Moser, Alain G. Georg, Finn L. Steinemann, David P. Rütti and Daniel M. Meier

Minimizing Oxidation of Freeze-Dried Monoclonal Antibodies in Polymeric Vials Using a Smart Packaging Approach

Nicole Härdter, Tim Menzen and Gerhard Winter

Towards quantification and differentiation of protein aggregates and silicone oil droplets in the low micrometer and submicrometer size range by using oil-immersion flow imaging microscopy and convolutional neural networks

Muhammad Umar, Nils Krause, Andrea Hawe, Friedrich Simmel and Tim Menzen

Stress Factors in Protein Drug Product Manufacturing and Their Impact on Product Quality

Tapan K.Da, Alavattam Sreedhara, James D. Colandene, Danny K. Chou, Vasco Filipe, Christoph Grapentin, Jim Searles, Twinkle R. Christian, Linda O. Narhi and Wim Jiskoot

Comparison of Syringes With Intravitreal Anti-VEGF Drugs: Particle Burden and Protein Aggregates in Brolucizumab, Aflibercept and Bevacizumab

Marc Schargus, Katharina Tatjana Kopp, Constanze Helbig, Andreas Frings, and Gerhard Winter

Forced degradation of cell-based medicinal products guided by flow imaging microscopy: explorative studies with Jurkat cells

A D Grabarek, W Jiskoot, A Hawe, K Pike-Overzet, T Menzen

View all

About us

Formulation Development

Analytical Services

About us

Latest news

Latest publications